|
|
加硫酶市场分析报告
|
Enzyme Replacement Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Products (Galsulfase, Velaglucerase Alfa, Laronidase, Asfotasealfa, Others), By Diseases (Exocrine Pancreatic Insufficiency (EPI), Pompe Disease, Scheie Syndrome, Maroteaux-Lamy Syndrome, Gaucher Disease, Others), By Route of Administrations (Oral, Parenteral, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F
... approved products such as Velaglucerase Alfa, Galsulfase, and Laronidase requiring this method ... : Enzyme Replacement Therapy Market, By Products: Galsulfase Velaglucerase Alfa Laronidase Asfotasealfa Others ...
Enzyme Replacement Therapy Market Size, Trends, Analysis, and Outlook By Product (Agalsidase Beta, Imiglucerase , Velaglucerase Alfa, Idursulfase, Galsulfase, Laronidase, Others), By Disease (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidosis, Exocrine Pancreatic Insufficiency (EPI), Others), By End-User (Hospitals, Infusion Centers & Home Healthcare Setting), by Region, Country, Segment, and Companies, 2024-2030
... Beta, Imiglucerase , Velaglucerase Alfa, Idursulfase, Galsulfase, Laronidase, Others), By Disease (Gaucher Disease ... Beta Imiglucerase Velaglucerase Alfa Idursulfase Galsulfase Laronidase Others By Disease Gaucher Disease ...
Global Enzyme Replacement Therapy Market Size study & Forecast, by Product (Agalsidase Beta, Imiglucerase, Velaglucerase Alfa, Idursulfase, Galsulfase, Laronidase, Others) by Disease (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidosis, Exocrine Pancreatic Insufficiency (EPI), Others), by End User (Hospitals, Infusion Centers & Home Healthcare Setting) and Regional Analysis, 2022-2029
... Beta Imiglucerase Velaglucerase Alfa Idursulfase Galsulfase Laronidase Others By Disease: Gaucher Disease ...
BioMarin Pharmaceutical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
... candidates. Approved products include Naglazyme (galsulfase), Kuvan (sapropterin dihydrochloride) tablets, Aldurazyme ...
Enzyme Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Imiglucerase), By Therapeutic Condition (MPS), By Route Of Administration (Oral), By End-use, By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days Enzyme Replacement Therapy Market Growth & Trends The global enzyme replacement therapy market size is estimated treach USD 17.26 billion by 2030, registering tgrow at a CAGR of 9.0% from ...
Enzyme Replacement Therapy (ERT) Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application
... , and India's BioMarin partnerships scale galsulfase for skeletal dysplasias. South Korea ... with VIMIZIM (elosulfase alfa), NAGLAZYME (galsulfase), and ALDURAZYME (laronidase), tallying 1.3 to 1.5 billion ...
3D Printing Medical Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (3 D Printer, 3 D Bioprinter, Material, Software, Services), By Application (Surgical Guides, Prosthetics, Implants), By Region and Competition, 2020-2030F
... : 3D Printing Medical Devices Market, By Component: Galsulfase Velaglucerase Alfa Laronidase Asfotasealfa Others ...
Mucopolysaccharidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
The mucopolysaccharidosis market has been comprehensively analyzed in IMARC's new report titled "Mucopolysaccharidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Mucopolysaccharidosis (MPS) refers to ...
Enzyme Replacement Therapy Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
... II. Developments prioritize long-term efficacy. Galsulfase: Expected growth of 5.8%-9.8%, for MPS VI. Trends ...
|
|
|
|
